Gain TherapeuticsGANX
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 19 institutions reported holding Gain Therapeutics Inc. (GANX) in their 13F filings, down 9 from Q2 2024. 2 opened new positions and 11 sold out. The largest holders were Gotham Asset Management ($7.4M), Greenlight Capital (DME Capital Management) ($1.0M) and Geode Capital Management, LLC ($484K). 3 famous investors held it, including Joel Greenblatt (0.1% of Gotham Asset Management's portfolio), David Einhorn (0.0% of Greenlight Capital (DME Capital Management)'s portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Gain Therapeutics Inc.
- CUSIP
- 36269B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $7.4M |
| Exits | 11 | $2.3M |
All 13F filers, Q2 2024 → Q3 2024: 489,425 shares bought and 1,851,437 shares sold, net −1,362,012 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Gotham Asset Management | 0.08% | New | 334,592 | $7.4M |
| Greenlight Capital (DME Capital Management) | 0.04% | No change | 566,130 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +48.0% | 271,972 | $484K |
| Vanguard Group Inc. | 0.00% | No change | 145,217 | $258K |
| BlackRock, Inc. | 0.00% | — | 84,924 | $151K |
| Jones Financial Companies LLLP | 0.00% | Add +664.3% | 53,500 | $106K |
| Renaissance Technologies | 0.00% | Reduce -55.1% | 53,264 | $95K |
| Northern Trust Corp. | 0.00% | No change | 44,944 | $80K |
| Prelude Capital Management, LLC | 0.00% | No change | 35,820 | $64K |
| State Street Corp. | 0.00% | No change | 34,437 | $61K |
| Sandhill Capital Partners LLC | 0.00% | New | 15,400 | $27K |
| UBS Group AG | 0.00% | Reduce -26.0% | 8,455 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +180.1% | 4,842 | $9K |
| Morgan Stanley | 0.00% | Add +45.5% | 4,800 | $9K |
| Simplex Trading, LLC | 0.00% | Reduce -47.0% | 4,801 | $8K |
| Creekmur Asset Management LLC | 0.00% | No change | 4,440 | $8K |
| Bank of America Corp. | 0.00% | Add +2.4% | 3,584 | $6K |
| Wells Fargo & Company | 0.00% | No change | 2,650 | $5K |
| Group One Trading LLC | 0.00% | Reduce -81.1% | 1,401 | $2K |
"% of holder's portfolio" is GANX's weight in each manager's 13F, not the share of Gain Therapeutics Inc. the manager owns.